HIV among the Latino community is on the rise with Latinos representing 21% of all new HIV infections, yet only 13% of the U.S. population. It is estimated that 23% of the 1.2 million people living with HIV in the United States in 2012 were Latinos. The rate of HIV infection in Latinos is more than three times that of non- Hispanic whites. Latino’s are usually in later stages of HIV disease when diagnosed and experience significant barriers to treatment. The CDC reports that 54.8% of Latinos living with HIV are retained in treatment with 43.3% prescribed antiretroviral treatment and 35.6% achieving viral suppression. Risk factors attributed to Latinos are intravenous drug use, multiple sexual partners and male- to- male transmission.
Antiretroviral therapy has dramatically increased the life span of HIV patients. Despite this, people living with HIV experience other devastating illnesses, such as cardiovascular disease (CVD), at a significant rate. Cardiovascular diseases and related conditions often seen in people living with HIV include coronary artery disease, heart attack, pulmonary hypertension, heart failure and stroke.
A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.
Drs Ian and Lynne Hampson, from the University’s Institute of Cancer Sciences and Dr Innocent Orora Maranga, Consultant in Obstetrics and Gynaecology at KNH in Nairobi examined Kenyan women diagnosed with HPV positive early stage cervical cancer who were treated with the antiviral HIV drug lopinavir in Kenya.
Continue reading HIV drug used to reverse effects of virus that causes cervical cancer
More than 100 Walgreens Pharmacies Designated Hepatitis C-Specialized to Meet Projected Patient Care Management Needs and Improve Medication Adherence.
With new advances in treatment therapy now available for hepatitis C patients, Walgreens (NYSE:WAG) (Nasdaq:WAG) today announced it is expanding access to Walgreens Connected Caresm hepatitis C program through its more than 100 hepatitis C-specialized pharmacies. Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence.
Continue reading Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance
The UNAIDS and Lancet Commission: Defeating AIDS – Advancing global health, reconvenes in London for final meeting on the future of HIV and global health.
LONDON/GENEVA, 13 February 2014—The UNAIDS and Lancet Commission: Defeating AIDS – Advancing global health is meeting in London on the future of AIDS and global health in the post-2015 era—the recommendations will be published in The Lancet later this year.
Continue reading UNAIDS and Lancet Commission to put forward recommendations on AIDS and global health for the post-2015 debate